IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Valeant Pharmaceuticals Intl

CUSIP: 91911K101 | 1 institutional holders

Quarters

Q1 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2015

Hound Partners, LLC2,643,123
11.6% of portfolio›$525.0K
StyleTurnoverLocationFiled
Hound Partners, LLC
2,643,123$525.0K11.6%ValueHighNew York, NY2015-05-15